Literature DB >> 32810515

Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis.

Matthew Greenhawt1, Marcus Shaker2, Julie Wang3, John J Oppenheimer4, Scott Sicherer3, Corinne Keet5, Keri Swaggart6, Matthew Rank7, Jay M Portnoy8, Jonathan Bernstein9, Derek K Chu10, Chitra Dinakar11, David Golden12, Carolyn Horner13, David M Lang14, Eddy S Lang15, David A Khan16, Jay Lieberman17, David Stukus18, Dana Wallace19.   

Abstract

Given the burden of disease and the consequences of a diagnosis of peanut allergy, it is important that peanut allergy be accurately diagnosed so that an appropriate treatment plan can be developed. However, a test that indicates there is peanut sensitization present (eg, a "positive" test) is not always associated with clinical reactivity. This practice parameter addresses the diagnosis of IgE-mediated peanut allergy, both in children and adults, as pertaining to 3 fundamental questions, and based on the systematic reviews and meta-analyses, makes recommendations for the clinician who is evaluating a patient for peanut allergy. These questions relate to when diagnostic tests should be completed, which diagnostic tests to utilize, and the utility (or lack thereof) of diagnostic testing to predict the severity of a future allergic reaction to peanut.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ara h 2; GRADE analysis; Peanut allergy; cost-effectiveness analysis; diagnosis; evidence to recommendation; likelihood ratio; meta-analysis; peanut components; practice parameter update; serologic IgE testing; skin prick testing; systematic review

Year:  2020        PMID: 32810515     DOI: 10.1016/j.jaci.2020.07.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

Review 1.  Current insights: a systemic review of therapeutic options for peanut allergy.

Authors:  Eimear O'Rourke; Hilary Tang; Andrew Chin; Andrew Long; Sayantani Sindher; R Sharon Chinthrajah
Journal:  Curr Opin Allergy Clin Immunol       Date:  2022-03-11

Review 2.  Ten tips for improving your clinical practice during the COVID-19 pandemic.

Authors:  Elissa M Abrams; Alexander G Singer; Matthew Greenhawt; David Stukus; Marcus Shaker
Journal:  Curr Opin Pediatr       Date:  2021-04-01       Impact factor: 2.893

Review 3.  Maillard Reaction Induced Changes in Allergenicity of Food.

Authors:  Jingkun Gou; Rui Liang; Houjin Huang; Xiaojuan Ma
Journal:  Foods       Date:  2022-02-12

4.  Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles.

Authors:  Mareen R Datema; Sarah A Lyons; Montserrat Fernández-Rivas; Barbara Ballmer-Weber; André C Knulst; Riccardo Asero; Laura Barreales; Simona Belohlavkova; Frédéric de Blay; Michael Clausen; Ruta Dubakiene; Cristina Fernández-Perez; Philipp Fritsche; David Gislason; Karin Hoffmann-Sommergruber; Monika Jedrzejczak-Czechowicz; Laurian Jongejan; Marek L Kowalski; Tanya Z Kralimarkova; Jonas Lidholm; Nikolaos G Papadopoulos; Todor A Popov; Nayade Del Prado; Ashok Purohit; Isabel Reig; Suranjith L Seneviratne; Athanassios Sinaniotis; Emilia Vassilopoulou; Serge A Versteeg; Stefan Vieths; Paco M J Welsing; E N Clare Mills; Thuy-My Le; Aeilko H Zwinderman; Ronald van Ree
Journal:  Front Allergy       Date:  2021-06-07

5.  Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice.

Authors:  Jay Portnoy; Christina E Ciaccio; Janet Beausoleil; George Du Toit; Stanley Fineman; Stephen A Tilles; June Zhang; Claire Lawrence; Mohamed Yassine; S Shahzad Mustafa
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-09       Impact factor: 3.373

6.  Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children.

Authors:  H K Brand; M W J Schreurs; J A M Emons; R Gerth van Wijk; H de Groot; N J T Arends
Journal:  Clin Mol Allergy       Date:  2021-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.